- Datametrex AI (TSXV:DM) has received another purchase order for COVID-19 test kits, this time from mining company Canadian Royalties
- The company has received numerous orders for kits from mining companies, announcing at least four in the last two weeks
- Datametrex will sell an initial 2,000 COVID-19 detection kits to Canadian Royalties
- The company has already secured enough kits to fill the order and will ship them directly from the manufacturer
- Datametrex AI (DM) is holding steady at C$0.12 per share
Datametrex AI (TSXV:DM) has received another purchase order for COVID-19 test kits, this time from mining company Canadian Royalties.
The Montreal-based miner operates a copper and nickel mine in Nunavik.
Over 1,000 people work on the mining company’s operations facilities, consisting of 600 direct employers and 400 subcontractors. An average of 400 people live and work on constant rotation on the Nunavik Nickel Project.
This latest announcement from Datametrex has begun to sound very familiar recently. The company has received numerous purchase orders for COVID-19 test kits from mining companies.
Datametrex gained the right to import COVID-19 test kits from South Korea in mid-April, and has been flooded with orders since then.
Yesterday, Datametrex released a nearly identical announcement, bringing its total orders from Canadian miners to two for the week. Last week, the company announced two purchase orders for kits from mining companies, one in Canada and one in Mali.
Canadian Royalties has made an initial purchase order for 2,000 units of COVID-19 qPCR Detection Kits from Datametrex. The kits have Health Canada authorisation, and are manufactured by 1drop Inc.
The kits will come with 2,000 three millilitre Universal Transport Medium Sterile Swabs with Skirted Tubes. Transpharm Canada, which Datametrex has a partnership with, will conduct and process the testing of Canadian Royalties’ workers.
Datametrex has already secured enough testing kits to fulfil the purchase order from the mining company. The items will be shipped directly from the manufacturer to Transpharm Canada’s lab.
Datametrex does not expect to pay any major upfront costs through the sale of the COVID-19 test kits.
The company’s CEO, Marshall Gunter, commented on the purchase order from the mining company.
“It has been a pleasure working with the team at Canadian Royalties. Their commitment to keeping their operations open in a responsible and safe manner is truly representative of the Canadian spirit we are proud to be a part of,” he said.
Datametrex AI (DM) is holding steady at C$0.12 per share at 3:04pm EDT.